Recombinant Protein Market INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2017–2025 © Coherent market Insights. All Rights Reserved REPORT DESCRIPTION Recombinant Protein Market - Insights The global recombinant protein market by Product Type (Hormones, Growth Factors, Cytokines, Plasma Protein Factor, Recombinant Metabolic Enzymes, Immune Checkpoint Regulators, and Others), By Application (Drug Discovery & Development, Biopharmaceutical Production, Basic Research, and Others), By End User (Biopharmaceutical Companies, Academic & Research Institutes, Contract Research Organizations, and Others), and Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 347.2 million in 2016 and is projected to exhibit a CAGR of 6.2% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Availability of wide number of innovative recombinant proteins from various sources such as human and animal, lack of suitable alternative for basic protein related therapies research, and increasing demand for biopharmaceutical products is expected to fuel growth of the recombinant protein market. Request Sample: https://www.coherentmarketinsights.com/insight/request-sample/1516 Manufacturers are involved in collaborations and acquisitions for drug discovery and development purposes. For instance, in 2017, Crown Bioscience (CBI), Inc. entered into collaboration with Jiangsu Qyun Bio-Pharmaceutical Co. Ltd. to develop CTLA-4 antibody. Moreover, in 2016, CBI acquired PreClinOmics, Inc., an in Vivo preclinical company, which specializes in early research in cardiovascular and metabolic disease and in 2016 CBI introduced six new recombinant cell lines GITR, ICOS, CD137, CTLA-4, OX40, and RANK immune checkpoints and receptors for biological studies, drug discovery, and development. © Coherent market Insights. All Rights Reserved REPORT DESCRIPTION In 2012, ProSpec-Tany Technogene Ltd. and LifeMap Sciences, Inc.—a wholly owned subsidiary of BioTime, Inc.—announced definitive agreement to offer 1,000 recombinant proteins and antibodies, to be used for stem cell research, drug discovery, and development biology. In 2014, BPS Bioscience, Inc. announced the introduction of 13 different mutant EZH2 complexes and two new assay kits for screening inhibitors of mutant EZH2. Key players in the company are focusing on expanding their geographic presence, in order to enhance their market share. For instance, in 2016, Sigma Aldrich Company Ltd. established nine new M Lab Collaboration Centers in Asia, North America, Europe, and Latin America for its life science business. The centers are expected to boost growth of its recombinant protein business. Manufacturers participate in international and national conferences to promote their products. For instance, in 2014, Novoprotein Scientific, participated in AAPS National Biotechnology Conference, which was dedicated to recent developments of protein recombinants worldwide. Browse 39 Market Data Tables and 40 Figures spread through 151 Pages and in-depth TOC on Recombinant Protein Market by Product Type (Hormones, Growth Factors, Cytokines, Plasma Protein Factor, Recombinant Metabolic Enzymes, Immune Checkpoint Regulators, and Others), By Application (Drug Discovery & Development, Biopharmaceutical Production, Basic Research, and Others), By End User (Biopharmaceutical Companies, Academic & Research Institutes, Contract Research Organizations, and Others), and Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and, Africa) - Global Forecast to 2025 Request Customization: https://www.coherentmarketinsights.com/insight/requestcustomization/1516 © Coherent market Insights. All Rights Reserved REPORT DESCRIPTION Key Takeaways of the Recombinant Protein Market: • The global recombinant protein market is expected to exhibit a CAGR of 2% over the forecast period (2017–2025), owing to product launches by manufacturers such as BioVision, Inc., and HumanZyme, Inc. • Growth of the recombinant protein market is driven by strong demand for applications such as drug discovery & development and basic research • Hormones segment is expected to exhibit high growth over the forecast period, owing to applications in research and development of therapies for various metabolic disorders such as diabetes and others • Asia Pacific region is expected to exhibit strong growth over the forecast period, due to activities such as research, and collaborations in the region. For instance, Amgen, Inc. collaborated with Simcere Pharmaceutical Group, a China-based company, to develop four biosimilars for the Chinese market in 2017. • Major players operating in the global recombinant protein market include Crown Bioscience, Inc., ProSpec Tany TechnoGene, Ltd., BPS Bioscience, Inc., Sigma Aldrich Company Ltd., Novoprotein Scientific, PeproTech, Inc., Feldan Bio, Inc., BioVision, Inc., HumanZyme, Inc., and GenScript Biotech Corporation Request Discount: https://www.coherentmarketinsights.com/insight/requestdiscount/1516 © Coherent market Insights. All Rights Reserved ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES INDUSTRY ANALYSIS CUSTOMIZED RESEARCH SYNDICATED RESEARCH MARKET INTELLIGENCE SERVICES CONSULT STUDIES COUNTRY SPECIFIC STUDIES © Coherent market Insights. All Rights Reserved ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators Private and Government organization Distributors, Retailors and Value Added Resellers Outsourcing Companies Healthcare IT Solutions Developers Universities and Business Schools. © Coherent market Insights. All Rights Reserved KEY STATS RESEARCH SOLUTIONS 100+ FEASIBILITY STUDIES Insights Published Per Year GLOBAL REPORTS 150+ Consulting Projects Till Date COUNTRY ANALYSIS CONSULT PROJECTS 125+ Clients Worldwide Per Year 110+ SURVEY RESEARCH EXCEL FORECAST DATABASE CUSTOMIZED SOLUTIONS COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: [email protected] For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights [email protected] +1-206-701-6702 © Coherent market Insights. All Rights Reserved
The global recombinant protein market by Product Type (Hormones, Growth Factors, Cytokines, Plasma Protein Factor, Recombinant Metabolic Enzymes, Immune Checkpoint Regulators, and Others), By Application (Drug Discovery & Development, Biopharmaceutical Production, Basic Research, and Others), By End User (Biopharmaceutical Companies, Academic & Research Institutes, Contract Research Organizations, and Others), and Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 347.2 million in 2016 and is projected to exhibit a CAGR of 6.2% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Availability of wide number of innovative recombinant proteins from various sources such as human and animal, lack of suitable alternative for basic protein related therapies research, and increasing demand for biopharmaceutical products is expected to fuel growth of the recombinant protein market.
© Copyright 2024 Paperzz
